Charles River Associates reported record second-quarter revenue of $210.8 million, a 12.8% year-over-year increase, and raised its full-year constant-currency revenue forecast to $805 million to $820 million. Non-GAAP diluted earnings per share rose 14.9% and EBITDA grew 15.3%, with eight practices representing 95% of revenue posting year-over-year gains. International revenue surged 32.9% organically, driven by Life Sciences and Antitrust & Competition Economics, while utilization improved to 77%. The company also expanded its credit facility to $400 million and returned $31.4 million to shareholders during the quarter.
CRA International IncRecord Q2 revenue, raised FY outlook, EPS and EBITDA growth, credit facility expansion, and shareholder returns.
